CRNX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Crinetics Pharmaceuticals (CRNX) Earnings Date & Reports

Industry: @Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRNX is expected to report earnings to fall 3.51% to -92 cents per share on March 18

Crinetics Pharmaceuticals CRNX Stock Earnings Reports

Q4'24

Est.

$-0.93

Q3'24

Missed

by $0.05

Q2'24

Missed

by $0.08

Q1'24

Missed

by $0.13

Q4'23

Missed

by $0.04

The last earnings report on November 12 showed earnings per share of -95 cents, missing the estimate of -91 cents. With 856.66K shares outstanding, the current market capitalization sits at 5.53B.

View a ticker or compare two or three

Compare

CRNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRNX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CRNX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

6055 Lusk Boulevard

Phone

+1 858 450-6464

Employees

290

Web

https://www.crinetics.com